IGF2BP1 and hepatocellular carcinoma: The functional characterization of the HBx-DNMT3A-PTPN13-IGF2BP1-c-Myc axis in HBV-induced HCC may be a useful biomarker to guide clinicians during HCC patient management, and molecules in this axis could be promising therapeutic targets to combat HCC.